Hope for Advanced Heart Failure Patients
The HeartMate II™ left ventricular assist device (LVAD) is a small, implantable heart pump designed to help the left side of your heart pump the blood your body needs. The first device of its kind to be approved by the U.S. Food and Drug Administration (FDA) for advanced heart failure, the HeartMate II has already provided over 23,000 people with new hope and improved health, allowing them to reclaim their lives.
How an LVAD can help heart failure patients
The HeartMate II LVAD can restore quality to the lives of advanced heart failure patients. A recent study showed that over 80 percent of HeartMate II device recipients were virtually free of heart failure symptoms at six months, and remained so for two years.1 Before the study, they had started out with severe symptoms, even at rest.
The HeartMate II is small enough to fit people of many sizes and ages, and is proven to work for many years. There are even several HeartMate II patients on support for more than 10 years.
Complications and risks
Complications of LVAD surgery are similar to the potential complications of any open-heart surgery procedure. You will be asked to sign a surgical consent form prior to the operation, as well as a consent form for blood transfusions. An LVAD should not be used in patients who cannot tolerate or are allergic to anticoagulation therapy. Common side effects include death, bleeding, cardiac arrhythmia, infection, respiratory failure, device malfunction, sepsis, right heart failure, renal failure, stroke, neurologic dysfunction, psychiatric episode, peripheral or device-related thromboembolic event, haemolysis, hepatic dysfunction, and myocardial infarction.
Consult your doctor about all possible benefits and risks of an LVAD.
See important safety information.